The murine embryonic stem cell test (EST) is an alternative testing method designed to assess potential developmental toxicity of compounds. The implementation of transcriptomics in the EST has been shown to reduce the culture duration and improve endpoint evaluation and is expected to result in an enhanced predictability and definition of the applicability domain. We evaluated the identification of developmental toxicity in the EST using two gene sets (''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes'') defined in our earlier studies. Nonexposed embryonic stem cells (ESC) differentiation cultures were sampled 0, 24, and 48 h after initiation of differentiation. Additionally, cultures exposed to 12 diverse well-characterized positive and negative developmental toxicants were isolated 24 h after the onset of exposure. Inhibition of ESC differentiation was evaluated in parallel by morphological scoring on culture day 10. Transcriptomics analysis was conducted using the Affymetrix Gene Chips platform. We applied principal component analysis on the basis of the two predefined gene sets to define the ''differentiation track'' that represents ESC differentiation. The significance of derivations in the gene expression-based differentiation track because of compound exposures were evaluated to determine developmental toxicity of tested compounds. We successfully predicted developmental toxicity using transcriptomics for 83% (10/12) and 67% (8/12) of the compounds, respectively, using the two predefined gene sets (''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes''). Our study suggests that the application of transcriptomics may improve the applicability of the EST for the prediction of the developmental toxicity of chemicals.
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Currently, regulatory hazard identification of chemicals is mainly based on animal studies. However, these studies require high numbers of experimental animals, significant amounts of test chemical, and have a long duration, which altogether make animal studies extremely costly. The need for new approaches has been advocated in a new testing paradigm in toxicology by the U.S. National Research Council (NRC) (NRC, 2007) . Their vision is driven by the need for more efficient tests preferably based on human models to predict chemical-induced pathway disturbance leading to human disease. The development of cell line-based models is being encouraged because such tests can be efficiently designed, which enables high-throughput screening.
One of the best studied cell line-based tests within developmental toxicology is the embryonic stem cell test (EST) (Genschow et al., 2004b) , which is therefore of particular interest as model to predict potential developmental toxicity, in line with the view of the NRC. The EST uses murine embryonic stem cells (ESC) that can be induced to differentiate toward contracting cardiomyocytes. Inhibition of this differentiation process by compound exposure can be microscopically observed and is used to evaluate the toxicity of the tested compound. Currently, this test is mainly used for prioritization of compounds for further testing in pharmaceutical industry; however, when optimized, the EST may also be used in regulatory settings to predict potential developmental toxicity. Transfer of the assay to a human cell line is a future option.
The aspects of the EST that will need improvement to allow implementation include characterization of the predictability, which is defined by the accuracy of the test model as determined by the percentage of false positives and false negatives. Second, the applicability domain of the EST, which pertains to its biological endpoint(s) as well as the chemical categories for which the test is suitable in terms of prediction (Hartung et al., 2004) , has not yet been defined. Finally, also the subjective endpoint evaluation and the relatively long culture duration are weaknesses of the EST. Together, these aspects are expected to improve by implementation of molecular techniques into the EST.
The first studies that implemented molecular endpoints into the EST focused on single markers for the prediction of developmental toxicity (Bigot et al., 1999; Seiler et al., 2004) . Subsequently, Chapin et al. illustrated the usefulness of studying compound-induced regulation of multiple genes and of pathway modulation to identify developmental toxicants (Chapin and Stedman, 2009; Chapin et al., 2007) as was also suggested by the NRC (NRC, 2007) .
For the identification of developmental toxicity using ESC differentiation cultures, we confirmed that gene set-based analyses are highly valuable (van Dartel et al., 2009a) . We identified 38 genes that were upregulated in unexposed 24-h ESC differentiation cultures, which were combined in a gene set and named ''Van_Dartel_heartdiff_24h.'' This novel gene set was uniquely downregulated in ESC differentiation cultures exposed to the developmental toxicant monobutyl phthalate (MBP), showing its potential in developmental toxicity evaluation. More recently, we developed an alternative tool for developmental toxicant identification in EST by using a continuous representation of ESC differentiation in time using principal component analysis (PCA), defined as the ''differentiation track'' (van Dartel et al., 2010b) . A differentiation track-derived gene set was identified, consisting of 26 differentiation-related genes responsive to a group of tested developmental toxicants, which was named ''EST biomarker genes'' (van Dartel et al., 2010a) . In that study, applying a differentiation track algorithm using ESC differentiationrelated gene sets, we successfully identified developmentally toxic compounds.
In the present investigation, we have studied the performance of our gene sets for the identification of developmental toxicity by testing the modulation of ESC differentiation by additional compounds using both the ''Van_Dartel_heart-diff_24h'' and the ''EST biomarker genes'' gene sets and applying the differentiation track approach. Our analyses show that, with a new and independent data set of compounds tested at single concentrations, the in vitro developmental toxicity prediction corresponded in 83 and 67% with the in vivo data for the ''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes'' gene sets, respectively. These findings suggest that our predictive gene signature approach may be useful in assessing potential developmental toxicity. A summary of in vivo developmental effects of the studied compounds is presented in Table 1 .
MATERIALS AND METHODS
Resazurin cell viability assay. The effect of compound exposure on cell number was determined using resazurin dye reduction, which is a measure for the number of viable cells per well (O'Brien et al., 2000) , as we described previously (van Dartel et al., 2009b) . For each compound, a minimum of five concentrations were tested in three independent experiments. Cultures were exposed to a maximum DMSO concentration of 0.2%, which did not affect cell viability. The resazurin reduction of exposed cells relative to control measurement was calculated and plotted against the test concentrations using PROAST software (Slob, 2002) . The cell survival at the concentrations tested in the transcriptomics experiment was calculated on the basis of the curve fit.
Pluripotent ESC culture and cardiomyocyte differentiation. Pluripotent murine D3 ESC (ATCC, Rockville, MD) were cultured in a monolayer in Dulbecco's Modified Eagle Medium-based (Gibco BRL, Gaithersburg, MD) medium supplemented with leukemia inhibitory factor (LIF; Chemicon, Temecula, CA), as described previously (Anon., 1999; van Dartel et al., 2009b) . In short, hanging drop cultures were set up to obtain embryoid bodies (EB) using single ESC suspensions in complete medium without LIF. (ECVAM, 1999; De Smedt et al., 2008; van Dartel et al., 2010b) . These EB cultures were used as the primary step for differentiation of ESC. Inhibition of cardiomyocyte differentiation was evaluated by calculating the mean scores of 24 differentiation culture relative to the mean scores of control cultures. In total, four classes of differentiation were defined: strongly beating differentiation cultures (multiple contracting foci and > 40% of the cells beating) received three points, moderately beating cultures (one or more contracting foci and 10-40% of the cells beating) were given a score of two, and weakly beating differentiation cultures (one contracting focus and < 10% of the cells beating) received only one point. Differentiation cultures without the presence of contracting cardiomyocyte foci were scored negative and received 0 points.
Inhibition of cardiomyocyte differentiation by compound exposure. ESC differentiation cultures were exposed from the EB stage at day 3 onward to effective concentrations of the selected test compounds that were calculated (on the basis of historic data) to inhibit ESC differentiation by 50% (ID 50 ) using PROAST curve fitting (Slob, 2002) . All cultures, including control nonexposed cultures, were exposed to noncytotoxic 0.2% DMSO concentrations for comparability reasons. Cultures were microscopically evaluated at day 10 of the culture (n ¼ 2) to assess the inhibition of cardiomyocyte differentiation, whereas parallel cultures were used for gene expression analysis at earlier time points as explained below.
RNA isolation and whole-genome gene expression profiling. RNA of compound-exposed cultures was isolated 24 h after the onset of exposure, which corresponds with culture day 4. DMSO-exposed control differentiation cultures were harvested after 0, 24, and 48 h from the EB stage at day 3, which corresponds with culture days 3, 4, and 5. Each experimental group consisted of eight replicates of which the cells were directly collected in RNA protect (Qiagen, Venlo, The Netherlands) to stabilize RNA. Total RNA was purified using the RNeasy plus mini kit (Qiagen) according to the manufacturer's instructions. The quantity of RNA in each sample was measured using a NanoDrop Spectrophotometer (NanoDrop technologies, Wilmington, DE), and RNA integrity was assessed on the 2100 Bioanalyzer (Agilent Technologies, Amstelveen, The Netherlands) using the RNA 6000 Nano Chip Kit (Agilent Technologies). Preparation of the RNA samples for gene expression analysis using the Mouse Genome 430 2.0 arrays (Affymetrix) was done as described previously (van Dartel et al., 2010a) . Quality controls were performed according to the manufacturer's instructions and were within acceptable limits for all arrays.
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Data analysis and statistics. Robust Multichip Average normalization of Affymetrix CEL files and probe to gene mapping were performed as we described previously (van Dartel et al., 2010a) . Of the probe set definitions included in the custom annotation, 16,331 probe sets defined by the Brainarray custom Chip Description File version 11 (http://brainarray.mbni.med.umich. edu/Brainarray/Database/CustomCDF) (Dai et al., 2005) and 4648 additional probe sets defined by Affymetrix chip annotation 26 were used in further analyses, giving a total of 20,979 probe sets. Probe sets for Affymetrix internal controls or probe sets that did not correspond to an Entrez Gene ID were not used in further analyses. Raw and normalized data are available from ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) under accession number E-MTAB-300.
Statistical analyses were carried out using the R statistical software environment (http://www.r-project.org) using log-transformed values. Maximal fold ratios (FR) in individual gene expression between the experimental groups were determined by comparing the average normalized signal values per group and were calculated as the maximum/minimum ratio. Genes that were significantly differentially expressed between any of the nonexposed experimental groups were identified by a one-way ANOVA on the normalized data using the cutoff criteria of a p < 0.001 and FR > 1.5. The percentage of commonly regulated genes was calculated relative to the limiting gene set.
Definition of the differentiation track. To visualize normal ESC differentiation, we defined the differentiation track of these cultures as we described previously (van Dartel et al., 2010b) . In short, PCA was performed with R using defined gene lists that visualize the continuous differentiation of ESC on the basis of gene expression dynamics that represent the differentiation track. Coordinates along the first and second principal component were calculated for each sample, and deviation of compound-exposed cultures from the differentiation track was analyzed by applying a Hotelling T-test to these coordinates compared with those of time-matched control cultures. Significant deviation from the differentiation track (p < 0.05) was considered characteristic for developmental toxicants.
To study the correlation between the degree of differentiation inhibition and the significance of differentiation track deviation, Spearman's rank correlation coefficient was calculated.
RESULTS

ESC Differentiation-Related Gene Regulation
The gene expression profiles of the unexposed ESC differentiation samples at 0, 24, and 48 h were compared revealing 3780 genes that were transcriptionally responsive to ESC differentiation using p < 0.001 (corresponding false discovery rate ¼ 0.0021) and FR > 1.5. We compared these genes with the 3579 genes that we identified previously as ESC differentiation-related genes using the same experimental design (van Dartel et al., 2010b) . In total, a large number of genes (2700 genes, 75.4%) were identified to be commonly regulated in both studies and showed similar differentiation dynamics (Fig. 1 ). Using p < 0.001 and FR > 1.0 for the present study, this overlap between differentiation-regulated genes was 91.5%, indicating that most of the nonoverlapping genes were still significantly regulated in the present study, but to a lesser extent ( Table 2) .
The unexposed experimental samples of this study and of our previous study were plotted using PCA using the genes that 
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were identified as differentiation-related genes in the previous study (3579 genes, Fig. 1C ) and in the present study (3780 genes, Fig. 1D ). Replicates within experimental groups clustered together, as well as experimental groups isolated after the same culture duration in the two different studies. Furthermore, the PCA plot showed that experimental groups appeared in chronological order, and continuous ESC differentiation could therefore be represented by the curve connecting these samples, which we named the ''differentiation track.'' The position of the time-matched experimental groups of our present study (triangles) compared with our previous study (circles) showed some variation, which was most likely caused by slightly different temporal progression of ESC differentiation between experiments.
Compound-Induced Effect on ESC Differentiation and Cellular Viability
ESC differentiation cultures were exposed to single test concentrations selected on the basis of historic data. Effects of the test compounds on ESC differentiation and cell viability were scored in cultures parallel to those analyzed for gene expression in the present study, and results are presented in Figure 2 . SACC and MMP did not affect ESC differentiation at high concentrations tested, which is in line with their absence of effects on embryonic development. Only mild effects on cell viability were observed in SACC-exposed cultures (85% cell viability). No effects on cell viability and, remarkably, also no effects on ESC differentiation were observed in the cultures exposed to the developmentally toxic compound MBP. On the other hand, the in vivo more potent phthalate MEHP and also FLU, HEX, TDI, and WARF affected ESC differentiation effectively in absence of cytotoxicity or proliferation inhibition (> 90% cell viability). Cultures exposed to NIF, MeHg, MTX, and CBZ also inhibited ESC differentiation, but these compounds also induced a moderate to strong reduction of cell number, ranging from 19% in CBZ-exposed cultures to 54% in MeHg-exposed cultures.
Compound-Induced Deviation from the Differentiation Track
To study inhibition of ESC differentiation by compound exposure, we applied the differentiation track algorithm using the predefined differentiation-related gene sets ''Van_Dartel_ Heartdiff_24h'' and ''EST biomarker genes.'' The majority of the genes within these sets were also differentially expressed among ESC differentiation cultures across time in the present study, namely, 32/38 of the ''Van_Dartel_heartdiff_24h'' and 22/26 of the ''EST biomarker genes'' gene set (Figs. 3A and  3B ). These predefined gene sets represent slightly different ESC differentiation dynamics as reflected by the differences in the projections of the differentiation tracks in the PCA plots.
FIG. 1.
Heatmap of the mean gene expression values of the unexposed control samples at 0, 24, and 48 h of differentiation in our previous (_prev; van Dartel et al., 2010a) and present study using the differentiated-related genes identified in our previous study (3579 genes; A) and in the present study (3780 genes, B). PCA plots based on ESC differentiation-related genes in our previous study (C) and the present study (D). Unexposed ESC differentiation samples of the previous study (circles) and the current study (triangles) are presented. van Dartel et al. (2010a) .
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Both gene sets could successfully be used to describe the differentiation track as shown in Figures 3C and 3D . The modulation of ESC differentiation was analyzed by calculating the significance of deviation of exposed cultures from control ESC differentiation using the two predefined gene sets ''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes'' (Table 3(A)). The nonsignificant deviation of SACC using the ''Van_Dartel_heartdiff_24h'' gene set and the nonsignificant deviation of MMP with both gene sets were in line with the in vivo nondevelopmentally toxic properties of these compounds. The majority of the 10 positive developmental toxicants deviated significantly from the time-matched unexposed cultures on the differentiation track, which was expected on the basis of their in vivo effects. MBP, HEX, and MeHg were falsely predicted as being nondevelopmentally toxic in one out of two predictions, although these p values were borderline nonsignificant for MBP (p value ¼ 0.061) and HEX (p value ¼ 0.053). The developmental toxicant NIF was consistently incorrectly predicted as a negative developmentally toxic compound using both gene sets. We also evaluated the performance of the ''Van_Dartel_heartdiff_24h'' gene set for the identification of developmental toxicity using data of our previous study (van Dartel et al., 2010a) (Table 3(B) ). Five out of the six compounds were correctly identified using this gene set.
An overview of the predictions of the compounds tested in this study using the differentiation track approach with the gene sets ''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes'' is shown in Table 4 (A and B), respectively. The overall accuracy of the predictions using the ''Van_Dartel_heart-diff_24h'' gene set was 83% (10/12). The two incorrect predicted compounds were positive developmental toxicants that were predicted to be negative (HEX and NIF, Table 3 ). The accuracy of the predictions using the ''EST biomarker genes'' was 67% because 8 out of 12 predictions were correctly predicted. The falsely predicted compounds included one negative compound (SACC) and three positive compounds (MBP, NIF, and MeHg, Table 3 ). Evaluation of the ''Van_Dartel_heartdiff_24h'' gene set using data of our previous study (van Dartel et al., 2010a) showed that 83% (5/6) of the compounds were correctly identified (Table 4(C)). MBP appeared to be the only misclassified compound, being falsely labeled as nondevelopmentally toxic.
Spearman correlation coefficients (R values) were calculated of the correlation between the significance of differentiation track deviation and the degree of ESC differentiation inhibition based on available data from our studies. The R values, À0.71 and À0.69, obtained for the ''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes,'' respectively, revealed that the significance of deviation from the differentiation track is partly dependent on the degree of ESC differentiation inhibition (Fig. 4) . Therefore, for correct prediction of developmental toxicity, the effect size of the concentration of the test compound used appears to be an important factor.
DISCUSSION
Reproducible Gene Responses in ESC Differentiation
The present study showed that gene expression signatures in ESC differentiation are highly reproducible between independently performed studies. As many as 91.5% of the previously identified differentiation-related genes (van Dartel et al., 2010a) were identified as significantly regulated in the present study.
We performed PCA to visualize the continuous differentiation of ESC on the basis of gene expression dynamics that represent the differentiation track. PCA has been shown previously to be a valuable approach to describe embryonic development (Sharov et al., 2003) , neural cell lineage differentiation (Aiba et al., 2006) , and ESC differentiation (van Dartel et al., 2010b) . In the present study, the differentiation tracks on the basis of the genes identified to be involved in ESC differentiation in both studies were very similar (Figs. 1C vs.  1D) . Furthermore, the differentiation tracks showed that the samples of the present study differed only slightly from the time-matched samples of our previous study. The variation was observed along the track, and therefore, this difference may be primarily explained by a slight variation in the timing of differentiation. In addition, also within experimental groups, variation of ESC differentiation was observed along the differentiation track, supporting the notion that the track represents continuous ESC differentiation.
The reproducibility of gene expression profiles of differentiating ESC facilitates the use of a predefined gene set for developmental toxicity prediction. Apparent variance in temporal progression of ESC differentiation between experiments is not expected to hamper the use of predefined gene sets because the genes within the gene sets also showed temporal regulation and thus follow the dynamics of ESC differentiation.
Differentiation Track-Based Evaluation of Developmental Toxicity
Studying gene expression signature in differentiation ESC allows the possibility to investigate compound-induced effects on multiple cellular processes. The present study shows that compounds that affected development either via proliferation or differentiation were detected in the EST protocol. Although effects on the mesodermal-derived cardiomyocyte differentiation have been classically used as the endpoint for evaluation of differentiation inhibition, also compounds affecting structures derived from other germ layers can potentially be discriminated using the EST (Genschow et al., 2004b) . This is explained by the presence of cells from the ectodermal and endodermal germ layers within the differentiation cultures (Doetschman et al., 1985; Leahy et al., 1999) , which resembles the in vivo situation, in which the mesodermal germ layer develops by induction between the ectoderm and endoderm germ layers (Larsen, 2001) . van Dartel et al., 2010a) van Dartel et al. (2009a) . b van Dartel et al. (2010a) . Asterisks indicate statistically significant deviation of compound-exposed from time-matched cultures on the differentiation track (p < 0.05). Significance values that correspond with the in vivo developmental toxicity of the compound are in bold.
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The predictive capacity of both gene sets appears promising in view of the accuracies that were calculated using data of a limited set of 12 test compounds tested at single concentrations. The accuracies obtained were 83% for the gene set ''Van_Dartel_heartdiff_24h'' and 67% for the gene set ''EST biomarker genes.'' Unfortunately, the negative control SACC was misclassified using the ''EST biomarker genes'' gene set. This could be explained by the cell viability results, which showed that SACC caused some degree of cytotoxicity at the concentration tested in the transcriptomics study. Regarding the false-negative compounds, two of which were observed using the ''Van_Dartel_heartdiff_24h'' set (HEX and NIF) and three using the ''EST biomarker gene'' set (MBP, NIF, and MeHg), two predictions appeared to be borderline nonsignificant (HEX and MBP) and one incorrect prediction may be caused by the observed large variation in ESC differentiation inhibition (MeHg, Fig. 2 ). Data analyses of our previous transcriptomics study showed that MBP was also incorrectly identified as being nondevelopmentally toxic using the ''Van_Dartel_heartdiff_ 24h'' gene set. The significance values for differentiation track deviation correlated well with limited differentiation inhibition (Fig. 4) , and this may explain the misclassifications of MBP and MeHg.
Remarkably, although the strong developmental toxicant NIF inhibited ESC differentiation as assessed on day 10 of the EST protocol, NIF was not identified as developmental toxicant using the differentiation track method. The regulation of 570 genes by NIF (not shown) included many genes that are known to play an important role in development, such as Hoxd9, Wnt8a, Tdgf1, and Shh. Regarding the significant number of NIF-regulated genes, it is not likely that the timing for studying gene expression was insufficient. Apparently, the effect of NIF was not reflected by the gene sets that were used for studying differentiation modulation. The gene sets used in the present study, ''Van_Dartel_heartdiff_24h'' and ''EST biomarker genes,'' will need further refinement to optimize van Dartel et al. (2009a) .
b van Dartel et al. (2010a) .
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Aspects for Further Optimization of Developmental Toxicant Identification in the EST
Obviously, compound concentration is an important factor when assessing the toxicity of compounds, as has been shown also in the EST (de Jong et al., 2009; Genschow et al., 2004a; van Dartel et al., 2009b) . In the present study, the identification of developmentally toxic compounds was based on gene expression data of compounds tested at single concentrations only, which represents the most economic gene array study design. With this approach, we were able to show that the degree of ESC differentiation inhibition correlated well with the significance of differentiation track deviation. Previous studies have shown that also the gene expression response is related to compound concentration (Andersen et al., 2008; Goetz and Dix, 2009) . Therefore, the prediction of developmental toxicants is expected to improve by analyzing transcriptomics responses of test compounds in a concentration-response design, and although significantly more cost intensive, this will be the subject of our future studies.
Additional improvements of our approach will include increasing the throughput of the assay using custom gene chips. In addition, future studies may be based on compound-induced gene signatures of human ESC (hESC). Implementation of these hESC is expected to improve the predictability of the assay (Adler et al., 2007) . Unfortunately, routine hESC culture as well as hESC differentiation protocols are still very labor intensive, and therefore the development of optimized culture protocols is essential for successful use of hESC in the EST.
Conclusions
In this transcriptomics study, we have demonstrated the application of gene expression analysis for the prediction of potential developmental toxicity by testing compounds at single concentrations. To our knowledge, this is the first study that evaluates this approach in the field of developmental toxicology. This approach may lead to improvements of the predictability and the characterization of the applicability domain of the EST, which may ultimately facilitate its incorporation as a test system for developmental toxicity in regulatory strategies. 
